Literature DB >> 16443388

Opposite effect of caveolin-1 in the metabolism of high-density and low-density lipoproteins.

To Quyen Truong1, Dominique Aubin, Philippe Bourgeois, Louise Falstrault, Louise Brissette.   

Abstract

Receptors of the scavenger class B family were reported to be localized in caveolae, the cell surface microdomains rich in free cholesterol and glycosphyngolipids, which are characterized by the presence of caveolin-1. Parenchymal hepatic and hepatoma HepG2 cells express very low levels of caveolin-1. In the present study, stable transformants of HepG2 cells expressing caveolin-1 were generated to address the effect of caveolin-1 on receptor activity. Compared to normal cells, these cells show higher (125)I-bovine serum albumin (BSA) uptake and cholesterol efflux, two indicators of functional caveolae. By immunoprecipitation, cell fractionation and confocal analyses, we found that caveolin-1 is well colocalized with the cluster of differentiation-36 (CD36) and the low-density lipoprotein (LDL) receptor (LDLr) but to a lesser extent with the scavenger receptor class B type I (SR-BI) in HepG2 cells expressing caveolin-1. However, caveolin-1 expression favors the dimerization of SR-BI. Two clones of cells expressing caveolin-1 were investigated for their lipoprotein metabolism activity. Compared to normal cells, these cells show a 71-144% increase in (125)I-LDL degradation. The analysis of the cholesteryl esters (CE)-selective uptake (CE association minus protein association) revealed that the expression of caveolin-1 in HepG2 cells decreases by 59%-73% LDL-CE selective uptake and increases high-density lipoprotein (HDL)-CE selective uptake by 44%-66%. We conclude that the expression of caveolin-1 in HepG2 cells moves the balance of LDL degradation/CE selective uptake towards degradation and favors HDL-CE selective uptake. Thus, in the normal hepatic parenchymal situation where caveolin-1 is poorly expressed, LDL-CE selective uptake is the preferred pathway.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16443388     DOI: 10.1016/j.bbalip.2005.12.004

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  7 in total

1.  High density lipoproteins selectively promote the survival of human regulatory T cells.

Authors:  Cesar M Rueda; Ana Lucia Rodríguez-Perea; Maria Moreno-Fernandez; Courtney M Jackson; John T Melchior; W Sean Davidson; Claire A Chougnet
Journal:  J Lipid Res       Date:  2017-04-04       Impact factor: 5.922

2.  Multimolecular signaling complexes enable Syk-mediated signaling of CD36 internalization.

Authors:  Bryan Heit; Hani Kim; Gabriela Cosío; Diana Castaño; Richard Collins; Clifford A Lowell; Kevin C Kain; William S Trimble; Sergio Grinstein
Journal:  Dev Cell       Date:  2013-02-07       Impact factor: 12.270

3.  Caveolin-1-mediated apolipoprotein A-I membrane binding sites are not required for cholesterol efflux.

Authors:  Soazig Le Lay; Macarena Rodriguez; Wendy Jessup; Carles Rentero; Qiong Li; Siân Cartland; Thomas Grewal; Katharina Gaus
Journal:  PLoS One       Date:  2011-08-12       Impact factor: 3.240

Review 4.  Lipid rafts: dream or reality for cholesterol transporters?

Authors:  Stéphane Orlowski; Christine Coméra; François Tercé; Xavier Collet
Journal:  Eur Biophys J       Date:  2007-06-19       Impact factor: 2.095

5.  Traumatic brain injury enhances neuroinflammation and lesion volume in caveolin deficient mice.

Authors:  Ingrid R Niesman; Jan M Schilling; Lee A Shapiro; Sarah E Kellerhals; Jacqueline A Bonds; Alexander M Kleschevnikov; Weihua Cui; April Voong; Stan Krajewski; Sameh S Ali; David M Roth; Hemal H Patel; Piyush M Patel; Brian P Head
Journal:  J Neuroinflammation       Date:  2014-03-03       Impact factor: 8.322

Review 6.  Scavenger receptor class B member 1 protein: hepatic regulation and its effects on lipids, reverse cholesterol transport, and atherosclerosis.

Authors:  Anthony P Kent; Ioannis M Stylianou
Journal:  Hepat Med       Date:  2011-04-08

Review 7.  Caveolae structure and function.

Authors:  Candice M Thomas; Eric J Smart
Journal:  J Cell Mol Med       Date:  2008-02-27       Impact factor: 5.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.